Previous studies have demonstrated that type I interferon response drives neuroinflammation and synapse loss in AD patients34, and higher levels of interferon-gamma were observed in patients with mild cognitive impairment (MCI) compared to controls35. This evidence concerns the gene IFNG and Cognitive impairment.